The delusion
The fallout from Johnson and Johnson’s (NYSE: JNJ) decision to shut down their insulin pump unit Animas continues to reverberate through the diabetes landscape. Yesterday Tandem (NASDAQ: TNDM) another insulin pump on the verge of collapsing announced they will attempt sell more shares in what likely is their last-ditch effort to stave off bankruptcy. Even if this effort is successful, and we are having a very difficult time defining just...
Knew this was coming
As we anticipated now that the Tandem (NASDAQ: TNDM) has completed the reverse stock split they are headed back to the capital markets – again – asking for money – again – and in the process diluting the stock – again – so they can waste more investor money – again. Per a company press release; “Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only...